Registry for the Improvement of Postoperative OutcomeS in Cardiac and Thoracic surgEry

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorCMC Ambroise Paré

About this trial

The registry for the improvement of postoperative outcomes in cardiac and thoracic surgery aims to prospectively collect data in order to test the association between various preoperative and per-operative variables ; and several postoperative outcomes such as mortality, shock, redo surgery, sepsis and extracorporeal life-support.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

all patients eligible for cardiac or thoracic surgery

Disqualifiers

non applicable

Trial population

All patients undergoing cardiac or thoracic surgery in CMC Ambroise Paré

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Cardiothoracic surgery

    Procedure/Surgery

    Cardiac or thoracic procedure

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

In-hospital mortality

death occurring in the same hospital where the operation took place before discharge from the hospital

Time frame
During follow-up, until discharge from hospital, up to 1 year.

Secondary outcomes

1

Postoperative shock

Use of catecholamines (dobutamine, norepinephrine and/or epinephrine) in order to achieve adequate cardiac output (cardiac index \> 2.2 l/min/m2), in the first 24 hours after surgery

Time frame
In the first 24 hours after surgery
2

Length of stay in the ICU (days)

length of stay in the intensive care unit after cardiac or thoracic surgery

Time frame
During follow-up, until discharge from the ICU, up to 1 year.
3

Total length of stay (days)

length of stay in the hospital, including preoperative period

Time frame
During follow-up, until discharge from the hospital, up to 1 year.
4

Mediastinitis

Incidence of mediastinitis in the postoperative period

Time frame
During follow-up, until discharge from the hospital, up to 1 year.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.